19.11.2014 • NewsAkzoNobelfraud

AkzoNobel US Subsidiary Said Defrauded of €53 million

A US subsidiary of AkzoNobel based in Chicago has been been defrauded of up to €53 million, the Dutch chemical producer said, without providing details.

The company said it had taken immediate action to stop the fraud when detected and that it might be able to reduce the financial impact. An independent legal counsel assisted by an independent audit firm has been assigned to investigate the matter, it added.

AkzoNobel said the fraud appeared to be an isolated incident not linked to its operational activities. The company did not indicate whether any of its own employees were involved.

 

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.